APA (7th ed.) Citation

Möhler, T., Neben, K., Kasper, B., Kordelas, L., Egerer, G., Görner, M., . . . Goldschmidt, H. (2002). Thalidomide plus CED chemotherapy as regimen for remission induction in poor-prognosis multiple myeloma prior to autologous or allogeneic haematopoietic stem cell transplantation. High dose therapy and transplantation of haematopoietic stem cells (2001).

Chicago Style (17th ed.) Citation

Möhler, Thomas, Kai Neben, Bernd Kasper, Lambros Kordelas, Gerlinde Egerer, Martin Görner, Anthony Dick Ho, and Hartmut Goldschmidt. "Thalidomide Plus CED Chemotherapy as Regimen for Remission Induction in Poor-prognosis Multiple Myeloma Prior to Autologous or Allogeneic Haematopoietic Stem Cell Transplantation." High Dose Therapy and Transplantation of Haematopoietic Stem Cells (2001) 2002.

MLA (9th ed.) Citation

Möhler, Thomas, et al. "Thalidomide Plus CED Chemotherapy as Regimen for Remission Induction in Poor-prognosis Multiple Myeloma Prior to Autologous or Allogeneic Haematopoietic Stem Cell Transplantation." High Dose Therapy and Transplantation of Haematopoietic Stem Cells (2001), 2002.